Winnie Chemutai Sum

Winnie Chemutai Sum

Auto-generated profile, based on publicly available information

Winnie Chemutai Sum

Department of Microbial Drugs, Helmholtz Centre for Infection Research GmbH (HZI), Inhoffenstraße 7, 38124 Braunschweig, Germany

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2019 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Closed access
CCClara Chepkirui
Clara Chepkirui
TCTian Cheng
Tian Cheng
WSWinnie Chemutai Sum
Winnie Chemutai Sum
JMJosphat Matasyoh
Josphat Matasyoh
CDCony Decock
Cony Decock
Marc StadlerMarc Stadler
Marc Stadler

14 February 2024 in Journal of Natural Products
Verified
Journal Article
Closed access
PPPatcharee Pripdeevech
Patcharee Pripdeevech
SKSarunpron Khruengsai
Sarunpron Khruengsai
CTChutima Tanapichatsakul
Chutima Tanapichatsakul
WAWael Mohamedy Afifi
Wael Mohamedy Afifi
WSWinnie Chemutai Sum
Winnie Chemutai Sum
Sherif ElsayedSherif Elsayed
Sherif Elsayed

30 January 2019 in AFRICAN JOURNAL OF BIOTECHNOLOGY
Verified
Journal Article
Open access
PDF file
CWChemutai Sum Winnie
Chemutai Sum Winnie
ASAbwao Indieka Stephen
Abwao Indieka Stephen
CJClement Matasyoh Josphat
Clement Matasyoh Josphat
Microbial diseases remain to be a major global public health challenge. Their devastating effects have been exacerbated by the development of drug resistant strains. On the other hand, the biodiversity of tropical Basidiomycetes fungi is well recognized as an untapped source of potential bioactive compounds for the development of novel antimicrobials. Thus, in the current study, Basidiomycetes’ fruiting bodies were collected from Mt. Elgon National Park forest in Kenya. The spores were cultured on Yeast Malt Agar media (YMG), leading to the establishment of 12 distinct pure fungal cultures of Basidiomycete strains, which were characterized using ribosomal internal transcribed spacer (ITS) DNA. They generally belonged to genera; Inonotus, Fomitiporia, Ganoderma, Skeletocutis, Perenniporia, Favolaschia, Hexagonia, Polyporus, Antrodia and Echinochaete. Fungal mycelia were further fermented in YMG, Q6½ (cotton-seed) and ZM½ (sugar-malt) liquid media for secondary metabolites’ production. These were extracted using ethyl-acetate and subjected to antimicrobial assays against Bacillus subtilis, Escherichia coli, Mucor plumbeus and Candida albicans. Antimicrobial activity was exhibited in 9 out of the 12 strains cultured, where antibacterial activity was more pronounced than fungal antagonism. Mycelial crude extracts from strains identified as Skeletocutis nivea and Favolaschia calocera demonstrated the highest activities against bacteria (B. subtilis) and fungal pathogen (C. tenuis), respectively with minimum inhibitory concentration (MIC) values of 4.69 µg/ml and <2.34 µg/ml, as compared to ciprofloxacin and nystatin controls which exhibited MIC values of <2.34 µg/ml each. In addition, crude extracts from Hexagonia sp and Inonotus pachyphloeus inhibited growth of E. coli at 300 µg/ml each, while M. plumbeus growth was inhibited by extracts from F. calocera and S. nivea at 37.5 and 300 µg/ml, respectively. These results clearly demonstrate that Basidiomycetes are a reservoir to antimicrobial fungal metabolites, which can be exploited as lead compounds to address drug resistance menace. Key words: Drug resistance, basidiomycetes, antimicrobial, fungal metabolites.

29 August 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
NMNico Mitschke
Nico Mitschke
WSWinnie Chemutai Sum
Winnie Chemutai Sum
KHKhadija Hassan
Khadija Hassan
MKMarco Kirchenwitz
Marco Kirchenwitz
HSHedda Schrey
Hedda Schrey
Marc StadlerMarc Stadler
Marc Stadler
Four previously undescribed drimane sesquiterpenoids were isolated from cultures of the wood-inhabiting basidiomycete Dentipellis fragilis along with two other drimanes that were previously only known as synthetic or biotransformation products.

2 August 2023 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
WSWinnie Chemutai Sum
Winnie Chemutai Sum
Sherif ElsayedSherif Elsayed
Sherif Elsayed
DGDidsanutda Gonkhom
Didsanutda Gonkhom
CDCony Decock
Cony Decock
RTRemy Bertrand Teponno
Remy Bertrand Teponno
Marc StadlerMarc Stadler
Marc Stadler
Chemical exploration of solid-state cultures of the polypore Fomitopsis carnea afforded two new C31 lanostane-type triterpenoid glycosides, forpiniosides B (1) and C (2) together with two known derivatives, namely 3-epipachymic acid (3) and (3α,25S)-3-O-malonyl-23-oxolanost-8,24(31)-dien-26-oic acid (4). The structures of the isolated compounds were established based on HRESIMS and extensive 1D and 2D NMR experiments. All the isolated compounds were assessed for their antimicrobial and cytotoxic activities. Among the tested compounds, forpinioside B (1) exhibited significant antimicrobial activity against Staphylococcus aureus and Bacillus subtilis at MIC values comparable to gentamycin and oxytetracycline (positive controls), respectively.

22 June 2023 in RSC Advances
Verified
Journal Article
Open access
PDF file
SKSarunpron Khruengsai
Sarunpron Khruengsai
PPPatcharee Pripdeevech
Patcharee Pripdeevech
CTChutima Tanapichatsakul
Chutima Tanapichatsakul
WSWinnie Chemutai Sum
Winnie Chemutai Sum
Mahmoud A. A. IbrahimMahmoud A. A. Ibrahim
Mahmoud A. A. Ibrahim
Sherif ElsayedSherif Elsayed
Sherif Elsayed
Two new metabolites 1 and 2 together with three known cylco-(D-Ala-D-Trp) (3), indole-3-carboxylic acid (4) and a cyclic pentapeptide clavatustide B (5), isolated from the submerged cultures of Lasiodiplodia chiangraiensis.